In addition, we recently demonstrated that a preexisting in situ Th1/Tc1 immune response—identified by the expression of the transcription factor T-box expressed in T cells (Tbet)—positively impacted prognosis in MSI as well as in MSS CRC [7]. The gene discussed is TBX21; the disease is colorectal carcinoma.